These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7489317

  • 1. MR spectroscopy of the breast.
    Merchant TE.
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):691-703. PubMed ID: 7489317
    [Abstract] [Full Text] [Related]

  • 2. Proton MR spectroscopy of the breast.
    Tozaki M.
    Breast Cancer; 2008 Nov; 15(3):218-23. PubMed ID: 18443899
    [Abstract] [Full Text] [Related]

  • 3. Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy.
    Cohen JS, Lyon RC, Chen C, Faustino PJ, Batist G, Shoemaker M, Rubalcaba E, Cowan KH.
    Cancer Res; 1986 Aug; 46(8):4087-90. PubMed ID: 3731076
    [Abstract] [Full Text] [Related]

  • 4. Current dilemmas and future perspectives for breast cancer screening with a focus on optimization of magnetic resonance spectroscopic imaging by advances in signal processing.
    Belkic K.
    Isr Med Assoc J; 2004 Oct; 6(10):610-8. PubMed ID: 15473589
    [Abstract] [Full Text] [Related]

  • 5. [Magnetic resonance spectroscopy of breast cancer].
    Knopp MV, Hess T, Bachert P, Ende G, Junkermann H, Hesterkamp T, van Kaick G.
    Radiologe; 1993 May; 33(5):300-7. PubMed ID: 8516439
    [Abstract] [Full Text] [Related]

  • 6. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
    Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS.
    NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
    [Abstract] [Full Text] [Related]

  • 7. Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review.
    Steen RG.
    Cancer Res; 1989 Aug 01; 49(15):4075-85. PubMed ID: 2663140
    [Abstract] [Full Text] [Related]

  • 8. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy.
    Cheng LL, Chang IW, Smith BL, Gonzalez RG.
    J Magn Reson; 1998 Nov 01; 135(1):194-202. PubMed ID: 9799694
    [Abstract] [Full Text] [Related]

  • 9. Investigation of breast cancer using two-dimensional MRS.
    Thomas MA, Lipnick S, Velan SS, Liu X, Banakar S, Binesh N, Ramadan S, Ambrosio A, Raylman RR, Sayre J, DeBruhl N, Bassett L.
    NMR Biomed; 2009 Jan 01; 22(1):77-91. PubMed ID: 19086016
    [Abstract] [Full Text] [Related]

  • 10. Possibilities for improved early breast cancer detection by Padé-optimized magnetic resonance spectroscopy.
    Belkić K, Belkić D.
    Isr Med Assoc J; 2011 Apr 01; 13(4):236-43. PubMed ID: 21598814
    [Abstract] [Full Text] [Related]

  • 11. MR imaging: its current and potential utility in the diagnosis and management of breast cancer.
    Kumar NA, Schnall MD.
    Magn Reson Imaging Clin N Am; 2000 Nov 01; 8(4):715-28. PubMed ID: 11149675
    [Abstract] [Full Text] [Related]

  • 12. High-resolution magic angle spinning MRS of breast cancer tissue.
    Sitter B, Sonnewald U, Spraul M, Fjösne HE, Gribbestad IS.
    NMR Biomed; 2002 Aug 01; 15(5):327-37. PubMed ID: 12203224
    [Abstract] [Full Text] [Related]

  • 13. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
    Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O.
    Technol Cancer Res Treat; 2006 Aug 01; 5(4):401-10. PubMed ID: 16866570
    [Abstract] [Full Text] [Related]

  • 14. Proton spectroscopy provides accurate pathology on biopsy and in vivo.
    Mountford C, Lean C, Malycha P, Russell P.
    J Magn Reson Imaging; 2006 Sep 01; 24(3):459-77. PubMed ID: 16897689
    [Abstract] [Full Text] [Related]

  • 15. [Proton magnetic resonance spectroscopy in the diagnosis of breast cancer].
    Meladze NV, Kuchuk PV, Abduraimov AB, Les'ko KA, Shariia MA, Malik DS, Matkhev S, Boĭko EA.
    Vestn Rentgenol Radiol; 2011 Sep 01; (4):31-6. PubMed ID: 22288145
    [Abstract] [Full Text] [Related]

  • 16. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
    Sterin M, Cohen JS, Mardor Y, Berman E, Ringel I.
    Cancer Res; 2001 Oct 15; 61(20):7536-43. PubMed ID: 11606391
    [Abstract] [Full Text] [Related]

  • 17. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
    Glunde K, Jie C, Bhujwalla ZM.
    Cancer Res; 2004 Jun 15; 64(12):4270-6. PubMed ID: 15205341
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Magnetic resonance imaging and spectroscopy of the breast.
    Stelling CB.
    Curr Opin Radiol; 1990 Oct 15; 2(5):746-50. PubMed ID: 2245156
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.